Protective Effect of Resveratrol Co-Administered with High Fat Diet on Blood Glucose Homeostasis and Thyroid Function in Rabbits
Cell Biology
Volume 3, Issue 1, January 2015, Pages: 19-24
Received: Jan. 15, 2015; Accepted: Jan. 22, 2015; Published: Feb. 2, 2015
Views 3966      Downloads 199
Jimoh A., Department of Human Physiology, Ahmadu Bello University, Zaria, Nigeria
Tanko Y., Department of Human Physiology, Ahmadu Bello University, Zaria, Nigeria
Ahmed A., Department of Pharmacognosy, Ahmadu Bello University, Zaria, Nigeria
Mohammed A., Department of Human Physiology, Ahmadu Bello University, Zaria, Nigeria
Ayo J. O., Department of Veterinary Physiology and Pharmacology, Ahmadu Bello University, Zaria, Nigeria
Article Tools
Follow on us
Consumption of high fat diet rich in calorie has been associated with an increased incidence of diabetes mellitus. Deep underlying relation between diabetes mellitus and thyroid dysfunction has already been established. The aim of these experiments was to investigate the protective effect of resveratrol co-administration with high fat diet on blood glucose level and serum triiodothyronine (T3) and thyroxine (T4) levels in rabbits. Thirty rabbits divided into six group of five animal (n = 5) each were used for the experiment: Group 1 = normal control (C), group 2 = high fat diet (HFD) only, group 3 = resveratrol 200 mg/kg (R200), group 4 = resveratrol 400 mg/kg (R400), group 5 = HFD + R200 and group 6 = HFD + R400. Our finding demonstrate significant (P < 0.05) decrease in blood glucose level in HFD group treated with resveratrol compared with HFD group only after 5 weeks of the experimental protocol. Significant (P < 0.05) decrease in T3 and T4 levels were also observed in HFD group compared to the control group. Slight increase in T3 level was observed in HFD group treated with resveratrol but not significant (P > 0.05) compared to HFD group only. T4 level in the HFD group showed significant (P < 0.05) decrease compared to HFD group treated with resveratrol. In conclusion, the result demonstrated that co-administration of resveratrol with HFD decrease blood glucose level and improved T3 and T4 level in HFD fed rabbits.
High Fat Diet, Blood Glucose Level, Rabbit, Thyroid Hormone
To cite this article
Jimoh A., Tanko Y., Ahmed A., Mohammed A., Ayo J. O., Protective Effect of Resveratrol Co-Administered with High Fat Diet on Blood Glucose Homeostasis and Thyroid Function in Rabbits, Cell Biology. Vol. 3, No. 1, 2015, pp. 19-24. doi: 10.11648/j.cb.20150301.13
Coller, F. A. and Huggins, C. B. (1927). Effect of hyperthyroidism upon diabetes mellitus: striking improvement in diabetes mellitus from thyroidectomy. Annals of Surgery, 86(6): 877-884.
Brenta, G. Danzi, S. and Klein, I. (2010). Potential therapeutic applications of thyroid hormones analogs. Nature Clinical Practice of Endocrinology and Metabolism, 3(9): 632-640.
Stanicka, S., Vondra, K., Pclikanova, T., Vlcck, P., Hill, M. and Zamrazil, V. (2005). Insulin sensitivity and counter-regulatory hormones in hyperthyroidism and during thyroid hormones replacement therapy. Clinical Chemistry and Laboratory Medicine, 43(7): 715-720.
Mitrou, P., Raptis, S. A. and Dimitriadis, G. (2010). Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocrine Reviews, 31(5): 663-679.
Singh, G., Gupta, V., Sharma, A. K. and Gupta, N. (2011). Frequently of thyroid dysfunction among diabetes in punjabi population. Advance in Bioresearch, 2: 3-9.
Klieverik, L. P., Coomans, C. P. and Endert, E. (2009). Thyroid hormone effects on whole-body energy homeostasis and tissue specific fatty acid uptake in vivo. Endocrinology, 150: 56339-5648.
Peppa, M., Varela, L. and Vazquez, M. J. (2010). Skeletal muscle insulin resistance in endocrine disease. Journal of Biomedicine and Biotechnology, 52(7): 8-15.
Keaney, J. F., Larson, M. G. and Vasan, R. S. (2003). Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arteriosclerosis Thrombosis Vascular Biology, 23: 434-439.
DeMarco, V. G., Johnson, M. S., Whaley-Connell, A. T. and Sowers, J. R. (2010). Cytokines abnormalities in the etiology of the cardiometabolic syndrome. Current Hypertens Rep, 12: 93-98.
Otani, H. (2011). Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxidant Redox Signal, 15: 1911-1926.
Adams, S. S., Imran, S., Wang, S. Mohammed, A. and Kok, S. (2011). The hypoglycemic effect of Pumpkins as Anti-Diabetic and functional medicines. Food research international, 44(4): 862-867.
Buettner, R., Scholmerich, J. and Bollheimer, L. C. (2007). High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring), 15: 798-808.
Baxter, J. D. and Webb, P. (2009). Thyroid hormones mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nature Reviews Drug Discovery, 8(4): 308-320.
Soufi, F. G., Mohammed-Nejad., D. and Ahmadieh, H. (2012). Resveratrol improves diabetic retinopathy possibly through stress-nuclear factor KB-apoptosis pathway. Pharmacological report, 64: 1504-1514.
Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E.M., Labo, J., Ferruzzi, M. G., Daries, P. and Marambaud, P. (2010). Amp-activated protein kinase signaling activity by resviratrol modulates amyloid-beta peptide metabolism. Journal of Biological Chemistry, 285(12): 9100-9101.
Sinha, K., Chaudhary, G. and Gupta, Y. K. (2002). Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Science, 71: 655-665.
Lamuela-Raventos, R. M., Romero-Perez, A. I.,Waterhouse, A. L. Torre-Boronat, M. C. (1995). Direct HPCC Analysis of Cis and trans-Resveratrol andpiceid isomers in spanish red vitis viniferawines. Journal of Agricultural and food chemistry, 43(2): 281-283.
Juan, M. E., Gonzalez-pons, E., Munuera, T., Ballester, J., Ridnguez-Gil, J. E and Planas, J. M. (2005). Trans- resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. Journal of Nutrition, 135: 757-760.
Joanne, M. A., Xiaomei, L., Christopher, Q. R., Brandi, P. and Min, Y. (2008). Resveratrol alleviates alcohol fatty liver in mice. American Journal of Physiology, 295(4): 833-842.
Beach, E. F. and Turner, J. J. (1958). An enzymatic method for glucose determination in the body fluids. Clinical Chemistry, 4: 468.
Rheney, C. C. and Kurk, K. K. (2000). Performance of three blood glucose meters. Annal of Pharmacotherapy, 34(3): 317-321.
Schuurs, A. H. W. M. and Van-Weemen, B. K.. (1977). Review,E nzyme-Immunoassay. Clinical. Chemistry Acta, 8 (5): 1.
Synder, P. J. and Utiger, R. D. (1972). Response to thyrotropin releasing hormones (TRH) in normal man. The Journal of Clinical Endocrinology and Metabolism, DOI:/10/1210/ 34-2-380.
Duncan, R. C., Knapp, R. G. and Miller, M. C. (1977). Test of hypothesis in population means. In: Introductory Biostatistics for the health sciences, John Wiley and Sons Inc. NY: 71-96.
Laaksonen, D. E., Lakka, H. M., Niskanen, L. K., Kaplan, G. A., Salonen, J. T. and Lakka, T. A. (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndromes in a prospective cohort study. American Journal of Epidemiology, 156: 1070-1077.
Grundy, S., Brewer, B., Cleeman, J., Smith, S. and Lenfant, C. (2004). Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institude/American Heart Association Conference on scientific issues related to definition. Circulation, 109: 433-438.
Dagher, Z., Park, Y. S., Asnaghi, V., I-Ioehn, T., Gerhardinger, C. and Lorenzi, M. (2004). Studies of rat and human retinas predict a role for the polyol pathway in human diabetes retinopathy. Diabetes, 53: 2401-2411.
Metzger, B. E., Gabbe, S. G., Persson, B., Buchanan, T. A. Catalano, P. A. and Damm, P. (2010). International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. Diabetes care, 33(3): 676-682.
Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Van Holle, A. Muccioli, G. G., Deldicque, L., Bindels, L. B., Pachikian, B. D., Sohet, F. M., Mignolet, E., Francaux, M., Larondelle, Y. and Delzenne, N. M. (2011). Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Journal of Nutrition and Biochemistry, 22: 712-722.
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P. And Auwerx, J. (2006). Resveratrol Improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1[alpha]. Cell, 127(6): 1109-1122.
Arai, I., Amagaya, S., Komatsu, Y.,Okada, M., Hayashi, T., Kasai, M., Arisawa, M. and Momose, Y. (1999). Improving effects of the extracts from Eugenia uniflora on hyperglycaemia and hypertriglyceryldemia in mice. Journal of Ethnopharmacology, 68: 307-314.
Eddouks, M., Jouad, H., Maghrani, M., Lemhadri, A. and Burcelin, R. (2003). Inhibition of endogenous glucose production accounts for hypoglycaemic effect of Spergularia purpurea in streptozotocine mice. Phytomedicine, 10: 594-599.
Ojewole, J. A. O. (2003). Hypoglycaemic effect of Sclerocarya birrea {A. Rich. HochSt.} (Anacardiaceae) stembark aqueous extract in rats. Phytomedicine, 10: 675-681.
Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S., Milne, J. C., Lambert, P. D., Mataki, C., Elliott, P. J. and Auwerx, J. (2008). Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metabolism, 8: 347-358.
Um, J. H., Park, S. J., Kang, H. and Yang, S. (2009). AMPK-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes, 59: 554-563.
Chen, W. P., Chi, T. C., Chuang, L. M. and Su, M. J. (2007). Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cells. Europeans Journal Pharmacology, 568: 269-277.
Chubb, S. A., Davis, W. A. and Davis, T. M. E. (2005). Interactions among thyroid function, insulin sensitivity, and serum lipid concentration: The Fremantle Diabetes study. The Journal of Endocrinology and Metabolism, 90(9): 5317-5320.
Decherf, S., Seugnet, I., Kouidhi, S., Lopez-Juarez, A., Clerget-Froidevaux, M. S. and Demenneix, B. A. (2010). Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression. Proceedings of the National Academy of Sciences of the United State of America, 107(7): 4471-4476.
Lopez, M., Varela, L. and Vazquez, M. J. (2010). Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine, 16(9): 1001-1008.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186